Contents

Search

hyaluronate gel for rectal injection (Solesta)

Indications: - treatment of fecal incontinence for patients >= 18 years of age Contraindications: - active inflammatory bowel disease - immunodeficiency - previous pelvic irradiation - significant rectal prolapse - active infection - bleeding - tumors or malformation of the anorectal area - hemorrhoids - exsiting implant in the anorectal region - allergy to hyaluronate-based gel Dosage: - 2 treatments, consisting of 4 injections each Adverse effects: - injection area pain & bleeding (most common) - infection & inflammation of anal tissue (less common) Procedure: - injected into a layer of tissue beneath the anus lining

Related

hyaluronate; hyaluronic acid; hyaluronan

General

hyaluronate-based injectable gel (Amvisc)

References

  1. FDA NEWS RELEASE: May 27, 2011 FDA approves injectable gel to treat fecal incontinence http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm257112.htm

Component-of

dextranomer/hyaluronate gel for rectal injection